Curriculum Vitaes
Profile Information
- Affiliation
- Department of Pharmacotherapeutics and informatics, Fujita Health University School of Medicine
- Degree
- 博士(医学)(名古屋大学)
- ORCID ID
https://orcid.org/0009-0005-2667-7057- J-GLOBAL ID
- 202001000562143382
- researchmap Member ID
- R000010558
Research Areas
4Research History
7-
Apr, 2024 - Present
-
Apr, 2023 - Present
-
Apr, 2023 - Present
-
Oct, 2020 - Mar, 2023
-
Jan, 2018 - Mar, 2023
Awards
3-
Sep, 2026
-
Mar, 2011
Papers
28-
Therapeutic Advances in Psychopharmacology, 16 1-12, Jul 30, 2026 Peer-reviewedBackground: Clozapine is associated with a high risk of central nervous system abnormalities. However, seizure risk related to interactions between clozapine and other antipsychotics remains poorly characterized, and the pharmacological mechanisms underlying these seizures are unclear. Objectives: We aimed to evaluate safety signals for seizures associated with clozapine augmentation by other antipsychotics and analyze the relationship between these signals and neurotransmitter receptor occupancy profiles. Design: A pharmacovigilance–pharmacodynamic analysis using a spontaneous reporting system. Methods: This pharmacovigilance study used VigiBase, an adverse drug reaction database maintained by the World Health Organization. Drug–drug interactions (DDIs) between clozapine and other antipsychotics were assessed using the Ω shrinkage measure model. The association between DDI signals and neurotransmitter receptor occupancy was evaluated using linear regression. Robustness was tested using four frequency statistical models: additive, multiplicative, combination risk ratio, and chi-square statistic models. Results: Of 38,758,077 reports in VigiBase between 1990 and 2024, 230,371 involved clozapine. Among antipsychotics classified under ATC code N05A, DDIs with clozapine were detected for amisulpride, chlorpromazine, haloperidol, lurasidone, olanzapine, penfluridol, risperidone, sulpiride, zotepine, and zuclopenthixol. A significant association between dopamine D 4 receptor occupancy and the point estimates of signal values was observed in the Ω shrinkage measure model (β = 0.295, 95% confidence interval: 0.119–0.471, p = 0.002) and replicated across all frequency statistical models. Conclusions: These findings suggest a potential role of dopamine D 4 receptor occupancy in seizures associated with clozapine augmentation by other antipsychotics. Further large-scale epidemiological studies are needed to validate these findings.
-
Pharmacological Research, 228 108201-108201, Apr 25, 2026 Peer-reviewed
-
Biological and Pharmaceutical Bulletin, 49(4) 683-690, Apr 11, 2026 Peer-reviewed
-
Scientific Reports, 15(1) 41783, Nov 25, 2025 Peer-reviewed
-
Neurobiology of Disease, 217 107151-107151, Oct 22, 2025 Peer-reviewed
Misc.
63-
日本薬学会年会要旨集(Web), 145th, 2025
-
パーキンソン病・運動障害疾患コングレスプログラム・抄録集, 19th 72-72, 2025
-
日本薬学会年会要旨集(Web), 145th, 2025
-
Clinical Nutrition ESPEN, 63 1235-1236, Oct, 2024 Peer-reviewed
-
日本病院薬剤師会東海ブロック・日本薬学会東海支部合同学術大会講演要旨集, 2022 (Web), 2022
-
日本コンピュータ外科学会誌, 23(4) 326,21(15)-6,-326, Nov, 2021
-
日本泌尿器科学会総会プログラム抄録集 (CD-ROM), 102nd ROMBUNNO.APP-184-473, 2014
-
日本臨床精神神経薬理学会・日本神経精神薬理学会合同年会プログラム・抄録集, 23回・43回 244-244, Oct, 2013
-
JOURNAL OF PHARMACOLOGICAL SCIENCES, 121 64P-64P, 2013
-
JOURNAL OF PHARMACOLOGICAL SCIENCES, 121 181P-181P, 2013
-
J. Res. Inst. Meijo Univ., 12(12) 35-41, 2013 Peer-reviewed
-
日本薬理学会近畿部会プログラム・要旨集 (Kinki Branch Meeting. Japanese Pharmacological Society), 121st(4) 43-4P, 2012
-
Annual Meeting of the Japanese Society of Toxicology, 35(Supplement) S190-308, May, 2010
-
Cancer Research, 70(8_Supplement) 3646-3646, Apr 15, 2010 Peer-reviewedLead authorAbstract Platinum(IV) [Pt(IV)] compounds are being developed worldwide as next-generation platinated drugs for a broad range of cancers. Since Pt(IV) compounds show relatively stable structural features, they are applicable for oral administration. The anti-cancer mechanism of Pt(IV) compounds has been proposed as that Pt(II) generated from Pt(IV) by endogenous reductants binds to DNA, resulting in the inhibition of transcription and replication of cancer cells. Here, we investigated the interaction manner between DNA, Pt(IV) and endogenous reductants such as ascorbic acid (AsA) and glutathione (GSH). cis-Diammine-tetrachloro-Pt(IV) [cis-Pt(IV)], which is a prodrug of cisplatin [cis-diammine-dichloro-platinum(II), cis-Pt(II)], was incubated with calf thymus DNA in the presence of AsA or GSH. In the presence of AsA, cis-Pt(IV) induced oxidative damage in calf thymus DNA, in which elevated amount of 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG), a biomarker for DNA oxidation, was observed. Hydroxyl radical (HO·) scavengers (ethanol and dimethylsulfoxide) suppressed the AsA-associated oxidative damage in a dose-dependent manner, whereas superoxide dismutase and catalase did not, suggesting that HO· was involved in the DNA oxidation. CD spectral change and crosslink formation in calf thymus DNA were also observed during this DNA oxidation, suggesting the cis-Pt(IV) reduction by AsA and the DNA conformational change by cis-Pt(II)-DNA binding. However, GSH did not show any 8-oxodG formation in calf thymus DNA likely due to its own HO· scavenging capability. GSH also suppressed the cis-Pt(II)-like conformational change probably by cis-Pt(II) sequestering from DNA by GSH. This GSH-cis-Pt(II) complex formation was also suggested by agarose gel electrophoresis. In order to reveal the detailed mechanisms of the complex formation, three thiol compounds (2-mercaptoethanol, 2-mercaptoacetic acid, and 2-mercaptoethylamine) were compared with regard to the reductive complex formation capabilities with cis-Pt(II). As observed in GSH-cis-Pt(IV)-DNA system, 2-mercaptoacetic acid and 2-mercaptoethylamine inhibited cis-Pt(II)-induced CD spectral change and crosslink formation in calf thymus DNA, whereas 2-mercaptoethanol did not, suggesting that thiol- and amine-/carbonyl-groups are involved in GSH-cis-Pt(II) complex formation via ligand exchange between these groups and Cl of cis-Pt(II). In this study, we revealed that the interaction manner of cis-Pt(IV) with endogenous reductants. In the reactions, AsA reduced Pt(IV) to Pt(II) and induced DNA-crosslink formation and DNA oxidation, where HO· was produced; GSH scavenged the radical and interfered with the DNA-crosslink formation. These data strongly indicate the importance of the proper Pt(IV) ligands which are suitable for Pt(IV) reduction by endogenous reductants without complex formation with the generated Pt(II). Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3646.
Books and Other Publications
1Presentations
81-
日本病院薬剤師会東海ブロック・日本薬学会東海支部 合同学術大会2026, Jul 5, 2026
Teaching Experience
5-
Apr, 2024 - Present臨床研究コーディネート実習 (Fujita Health University)
-
Apr, 2024 - Present実務実習事前講義・演習 (Meijo University)
-
Apr, 2023 - PresentTraining, Pharmacotherapeutics and informatics (Fujita Health University)
-
May, 2024 - Jul, 2024M1細胞から個体へ (Fujita Health University)
-
Apr, 2023 - Mar, 2024M3医学研究演習 (Fujita Health University)
Professional Memberships
7-
Jun, 2025 - Present
-
Apr, 2025 - Present
-
Oct, 2024 - Present
-
Nov, 2023 - Present
-
Jun, 2023 - Present
Research Projects
11-
科学研究費助成事業, 日本学術振興会, Apr, 2026 - Mar, 2029
-
若手研究者のための基礎・臨床研究推進助成金, 一般社団法人 日本認知症予防学会, Sep, 2026 - Sep, 2027
-
Apr, 2025 - Mar, 2027
-
Grants-in-Aid for Scientific Research Grant-in-Aid for Early-Career Scientists, Japan Society for the Promotion of Science, Apr, 2022 - Mar, 2026
-
研究助成, 公益財団法人 日東学術振興財団, Dec, 2023 - Dec, 2025